Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational s

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational s

Item

http://www.wikidata.org/entity/Q34288593

Q34288593

about

Invasive mold infections in solid organ transplant recipients Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage.ERG11 Gene Mutations and MDR1 Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis.Novel antifungal drugs against fungal pathogens: do they provide promising results for treatment?Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011 Phylogenetic relationships matter: antifungal susceptibility among clinically relevant yeasts.Effectiveness of primary anti-Aspergillus prophylaxis during remission induction chemotherapy of acute myeloid leukemia Our 2014 approach to breakthrough invasive fungal infections.Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit.Early diagnosis of invasive mould infections and disease.Antifungal prophylaxis in newly diagnosed AML patients-Adherence to guidelines and feasibility in a real life setting.Lichtheimia Infection in a Lymphoma Patient: Case Report and a Brief Review of the Available Diagnostic Tools.Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.Synthesis, characterization and antifungal activity of chemically and fungal-produced silver nanoparticles against Trichophyton rubrum.Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis.Retrospective analysis of goal drug level attainment of posaconazole for invasive fungal infection prophylaxis in patients with acute myeloid leukemia pre- and post-switch to tablet formulation.Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study.Editorial: Advances in Aspergillus fumigatus Pathobiology.Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation and Association With Occurrence and Outcome of Invasive Aspergillosis.Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.Susceptibility profiles of amphotericin B and posaconazole against clinically relevant mucorales species under hypoxic conditions.Prevention of invasive fungal infections in patients with acute myeloid leukaemia: results of a single centre retrospective observational study with the use of posaconazole versus conventional mould-active azoles.Isavuconazole and nine comparator antifungal susceptibility profiles for common and uncommon Candida species collected in 2012: application of new CLSI clinical breakpoints and epidemiological cutoff values.An invisible threat: mutation-mediated resistance to triazole drugs in Aspergillus.Celebrating 40 years of progress in bone marrow transplantation: a report from the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation.Rhodotorula mucilaginosa as a cause of recurrent pulmonary infection and liver infiltration in a patient with CLL.Catheter-Related Trichosporon asahii Bloodstream Infection in a Neutropenic Patient with Myelodysplastic Syndrome.Invasive Aspergillosis in Children: Update on Current Guidelines

P2860

Q26823811-DBF9D54F-980F-4AFB-8B3C-E25C82342D51 Q30840066-534C53A5-882B-4A6B-BA28-BBFC56A31A4C Q33573641-5F965AF7-83A6-44E3-BB1B-02F2AD2945D9 Q33843670-B9F76650-4013-4892-993E-5E3428571786 Q35220799-C556DA9E-0F08-4DFE-B369-90C3CEA08C1C Q35672258-2346E3A0-A601-4CD9-B10C-ACFCE363D0E6 Q35881360-396BF93F-2FAA-4861-96D8-38A13540DAB1 Q37544662-A5205E48-CCB0-4583-A780-DF277EB9D631 Q37643638-9AF9FE36-5A7D-44C3-A481-CE53DE5E8599 Q37713068-B26E886D-23C6-4BAF-A58B-5C5D147B30B1 Q38223105-0A49028A-8186-4071-BF9B-7B5B1ED6A594 Q38285488-B38CF824-C8CB-452D-8366-FAF67E3B06D8 Q38620631-2E790F16-13EC-4896-BA1E-A5F6CE56AF68 Q38738085-D8738E2E-1BFF-446B-B76B-67AC590903DF Q38786258-80A447E0-715A-4581-860E-49FCD7DB5F04 Q38817878-46BFB5EB-FE84-466F-B716-F287F236D5AD Q38960267-217DCEA5-BE3A-490A-B430-0CB0AAC91E1C Q39126938-A876482E-618E-4E33-9150-D71F6D0F32C7 Q39367509-57E3E924-9AA3-49CD-88EA-89016BAB5329 Q39673852-D5E811DA-8067-49C9-B243-CEDE51F07434 Q40109740-BB7F2223-BC94-459B-9E6D-ECCD532217DE Q40562624-A64F0BB6-348B-45F3-AC39-560CF40FDC2F Q40794362-216237AE-EF83-450C-A3BF-8B86BC2E65A6 Q41444940-F8909FC9-CFB0-4F8D-A451-08036F277B7D Q41887639-7F255EC1-601B-495C-9B4A-DE7B0FF9FCF2 Q42243344-D555761E-BD65-4BBA-806C-9E361AF3400F Q43156890-7B391126-175E-4395-B507-B8F334B721D6 Q44968373-C84497DB-3BD5-4CC2-858E-79223D861FE1 Q46876288-A0512A7C-06B5-4B80-B792-B37491EB6CCD Q47149131-2487506F-BDDA-483B-81B4-F70701F70F08 Q48059612-9ABF0F4A-CE35-4E9E-8424-9D194481ED7D Q48200992-F328F71E-35F2-4108-89D7-69E5DD1B0E17 Q55519155-13CDCA58-8735-4B6C-BADF-5CCF63F57C67 Q58775551-5100547F-7F0B-4EBF-90AB-0CD9DE4D59E9

P2860

Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational s

Item

http://www.wikidata.org/entity/Q34288593

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu